secwatch.observer — SEC 8-K summary
======================================

Issuer:     uniQure N.V. (QURE)
CIK:        0001590560
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001104659-24-076568
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

uniQure sells Lexington manufacturing facility to Genezen for $25M, reduces cash burn $40M/year
--------------------------------------------------------------------------------

- Consideration $25M: $12.5M of Series C preferred stock and $12.5M convertible note (8%, 63-month maturity).
- Genezen to manufacture HEMGENIX commercial supply; CEO Matt Kapusta joins Genezen board after close.
- Company expects to reduce annual cash burn by ~$40M and repay $50M debt, saving interest expense.
- Majority of Lexington employees offered jobs at Genezen; transaction expected to close early Q3 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590560/000110465924076568/0001104659-24-076568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590560/000110465924076568/tm2418608d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-076568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer